Cooper Companies (NYSE:COO) released its quarterly earnings results on Thursday. The medical device company reported $2.65 earnings per share for the quarter, topping analysts’ consensus estimates of $2.64 by $0.01, Bloomberg Earnings reports. Cooper Companies had a return on equity of 16.00% and a net margin of 16.45%. The firm had revenue of $561.50 million during the quarter, compared to the consensus estimate of $558.86 million. During the same quarter in the prior year, the firm posted $2.28 EPS. The business’s revenue was up 8.3% on a year-over-year basis. Cooper Companies updated its FY18 guidance to $11.35-11.65 EPS.

Shares of Cooper Companies (NYSE COO) opened at $238.80 on Friday. The firm has a market capitalization of $11,457.55, a PE ratio of 25.03, a P/E/G ratio of 1.95 and a beta of 0.54. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. Cooper Companies has a 12 month low of $165.98 and a 12 month high of $256.39.

A number of research firms recently weighed in on COO. J P Morgan Chase & Co restated a “hold” rating and issued a $235.00 price target on shares of Cooper Companies in a research note on Tuesday, September 12th. Oppenheimer restated a “hold” rating and issued a $250.00 price target on shares of Cooper Companies in a research note on Tuesday, September 12th. Stifel Nicolaus reiterated a “buy” rating and set a $265.00 price objective (down previously from $275.00) on shares of Cooper Companies in a research report on Friday. Zacks Investment Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. Finally, Robert W. Baird reiterated a “buy” rating and set a $273.00 price objective (up previously from $267.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $259.70.

In related news, Director Gary S. Petersmeyer sold 3,977 shares of the firm’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/12/07/cooper-companies-coo-issues-quarterly-earnings-results.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.